Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)

Julie Bernhardt(Florey Institute of Neuroscience and Mental Health), Peter Langhorne(University of Glasgow), Leonid Churilov(The University of Melbourne), Bent Indredavik, Geoffrey A. Donnan(The Royal Melbourne Hospital), Fiona Ellery(Florey Institute of Neuroscience and Mental Health), Amanda G. Thrift(Monash Health), Jan Chamberlain(The University of Melbourne), Torunn Askim, Christopher M. Reid(The University of Melbourne), Rob Carter, Marj Moodie(Deakin University), Judith Frayne, Richard I. Lindley(Westmead Hospital), Sandy Middleton(St Vincent's Health), Brooke Parsons, Janice Collier(Deakin University), Velandai Srikanth(Mount Sinai Hospital), Main Investigators MIs, Stephen Read, Christopher Bladin, Phillip Bath, Cathy Said, Helen Dewey(Deakin University), Richard Lindley(Deakin University), Julie Bernhardt(Deakin University), Janice Collier(Deakin University), Marjory Moodie(Deakin University), Helen M. Dewey(Eastern Health), Australia: Julie Bernhardt(Deakin University)
Neurology
February 18, 2016
Cited by 219


Related Papers